Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Almanij
Antwerp, Belgium
- Ownership
- Private
- Development stage
- Other
01
Overview
Almanij (Algemene Maatschappij voor Nijverheidskrediet) was a prominent Belgian financial holding company that played a central role in the European banking and insurance sectors. Historically, it served as the primary shareholder of Kredietbank and later the KBC Bank and Insurance Holding Company. While not a dedicated life sciences or biotech firm, Almanij held significant diversified interests, including a controlling stake in Gevaert, which in turn owned a major portion of Agfa-Gevaert, a company with substantial operations in healthcare imaging and diagnostic systems. In 2005, Almanij merged with its subsidiary, KBC Bank and Insurance Holding Company, to simplify the group's structure and form the current KBC Group.
- Industry
- Investors
Beyond the preview
Go deeper on Almanij.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Almanij.